About the Company

One of the country's leading pharmaceuticals, Ferozsons Laboratories Limited (PSX: FEROZ) was established in 1956 as one of the first pharmaceutical manufacturing companies in Pakistan. In 1960, it became the first Pakistani pharmaceutical company to be listed on the Karachi Stock Exchange. The company is a multiple-time recipient of the KSE Top 25 Companies Award. Its market capitalisation is north of Rs 26 billion.

Ferozsons is the only company in Pakistan to maintain exclusive agreements with numerous international partners for distribution, selling, and co-manufacturing of products, including the Bagó Group in Argentina; BioGaia of Sweden; Biofreeze of Hygenic Corp; PanTheryx, Boston Scientific, and Gilead Sciences, Inc in the US. Through a range of branded generics and in-licensed products, Ferozsons has established a leading presence in the areas of cardiology, gastroenterology, hepatology, oncology, dermatology and anti-infective treatments.

Prior Performance

Ferozsons has grown exponentially, particularly over the past two fiscals. The company boasts unprecedented five-year sales CAGR of 54.7 percent. However, gross margins have tumbled a bit due to the shift in the product mix, but the net margins have been maintained.